Navigation Links
Ludlow Research Issues Opinion on PMBS Based on Low Market Cap Valuation

SCHOFIELD, Wis., April 24, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (PMBS: OTCBB), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced that Ludlow Research had issued a research opinion on the company and its flagship product, LipiGesic® M.
Report Highlights

- Non-Prescription Product to Treat Migraine Headaches
- Product Shown to Outperform #1 Prescription Competitor
- Holds Patent on Product
- Product Currently Available Walgreen's and CVS/pharmacy stores Nationwide
- Expanding Retail Chain-Store Distribution
- Launching Marketing and Distribution Campaign
- 34 Million Shares Outstanding
- Market Cap just under $1 Million

PuraMed has contracted both bulk manufacturing and packaging firms to assist in the planned national expansion of LipiGesic M, their over-the-counter migraine relief product. The Company commented that they had selected Hillestad Pharmaceuticals as their fully licensed OTC drug manufacturer, with both Unette Corporation and Proteus Packaging to assist in packaging of products for store shelves.
This comes on the heels of news that their over-the-counter migraine pain reliever product was currently in Walgreen's and CVS/pharmacy stores nationwide, and PuraMed BioScience plans to expand that retail placement to an additional 21,000 targeted retail outlets, including mass merchandisers such as Wal-Mart and Target; food-store chains such as SuperValu, Kroger, and Safeway; as well as regional drugstore chains.

Current Valuation
Based on current and planned distribution to some of the nation's largest retail drug chains, and having the infrastructure to fulfill orders, PMBS now has all the pieces in place to expand product sales. With just around 34 million common shares outstanding, and a market cap valuation of around $850,000 Ludlow Research feels there could be some good speculative upside potential.

To view the full report, and access risks, disclosures, and potential outlook visit

About PuraMed BioScience, Inc.
PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to LipiGesic M, PuraMed BioScience plans to launch LipiGesic H for tension-type headaches and LipiGesic PM, which provides a remedy for insomnia and other sleep disorders.

Forward-Looking Statements
This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties that may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Melissa Diaz ,
South Street Media, Inc
Phone: (917) 937-8968

SOURCE PuraMed BioScience, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Musculoskeletal Network covers the Osteoarthritis Research Society International Conference
2. Nephrology & Urology Devices Market is Expected to Reach USD 20.5 Billion Globally in 2018: Transparency Market Research
3. Express Scripts Research Shows Prescription Drug Utilization Declines for Payers of Workers Compensation
4. Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy Adds The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
5. X-Ray Market (Portable, Handheld, Digital Radiography, Computed Radiography, Flat Panel Detection Systems, Mammography) is Expected to Reach USD 9.8 Billion Globally in 2018: Transparency Market Research
6. Serina Therapeutics Announces Worldwide Exclusive License Agreement with The Scripps Research Institute for Click Chemistry
7. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
8. Global Medical Robotic Systems Market is Expected to Reach USD 13.64 Billion by 2018: Transparency Market Research
9. Breast Pumps Market Is Expected to Reach USD 1.03 Billion Globally in 2018: Transparency Market Research
10. Jeffrey Epstein, New York Philanthropist, Funds Pioneering Cancer Metastasis Research at Mount Sinai
11. New Research Reveals Link between Marijuana and Inappropriate Use of Pain Medications, other Prescription Drugs
Post Your Comments:
(Date:11/24/2015)... 2015  Thanks to a donor with a personal ... Center,s Sister Diane Grassilli Center for Women,s Health now ... San Francisco . Fred ... with a gift of $617,320 that allowed the Center ... Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography ...
(Date:11/24/2015)... Nov. 24, 2015  Natera, Inc. (Nasdaq: ... genetic testing and the analysis of circulating ... present at the 27 th  Annual Piper ... 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, Ph.D., CEO of ... business activities and financial outlook. ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... Charitable giving is at ... are made in the last five weeks of the year totalling over $358 billion ... 2012 to connect the nation’s charities with those individuals who want to “give back” ...
(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... ... sizes, has launched their Black Friday sale a week early, offering 40% off ... to transform the intimate apparel industry through both mobile fit technology and the ...
(Date:11/24/2015)... Los Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... author explored the different restrictions and variables that determine which patients are or are ... are those patients that have a BMI over 40, are more than 100 pounds ...
(Date:11/24/2015)... ... November 25, 2015 , ... Catalent ... for drugs, biologics, consumer health and global clinical supply services, today announced that ... Clinical Trial Supply East Asia Conference, to be held at the InterContinental Seoul ...
(Date:11/24/2015)... ... November 24, 2015 , ... DMG Productions announced that they ... airing first quarter 2016 via Discovery Channel. Dates and show times TBA. , Aphria, ... is in the business of producing and supplying medical marijuana pursuant to the Marijuana ...
Breaking Medicine News(10 mins):